Timothy E. Ritter

35 papers receiving 1.9k citations

Timothy E. Ritter's Hit Papers

Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis 2024 · 53 citations
530+1+3Years since publication100200300

Peers

Timothy E. Ritter
Comparison fields: 5 of 68
  • Genetics 1.4k
  • Gastroenterology 192
  • Rheumatology 82
  • Infectious Diseases 98
  • Immunology 55
Replace Robert Hardi with:
Robert Hardi United States
Kristin Kaasen Jørgensen Norway
Eric A. Vasiliauskas United States
Bella Ungar Israel
Rosa Coelho Portugal
Arvind Ramadas United Kingdom
Rebecca Saich United Kingdom
Nick A. Watkins United Kingdom
Lauranne A. A. P. Derikx Netherlands
Susan Greenbloom United States
Timothy E. Ritter relative to Robert Hardi United States Robert Hardi's profile →
Citations per field
00.5×2×4×6.4×
Robert Hardi · 1×
Citations per year

Countries citing papers authored by Timothy E. Ritter

Since Specialization
Citations

This map shows the geographic impact of Timothy E. Ritter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy E. Ritter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy E. Ritter more than expected).

Fields of papers citing papers by Timothy E. Ritter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy E. Ritter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy E. Ritter. The network helps show where Timothy E. Ritter may publish in the future.

Co-authors

The 25 scholars most cited alongside Timothy E. Ritter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timothy E. Ritter Line = papers co-authored together Timothy E. Ritter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
Hit paper breakdown →
2021352
2 2016272
3
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
Hit paper breakdown →
2023256
4
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
Hit paper breakdown →
2022238
5
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
Hit paper breakdown →
2023181
6 2016119
7 202370
8
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis
Hit paper breakdown →
202453
9 201952
10 202351
11 202036
12 202234
13 202331
14 202228
15 202326
16 202225
17 202223
18 202523
19 202020
20 202211

About Timothy E. Ritter

Timothy E. Ritter is a scholar working on Genetics, Infectious Diseases, Gastroenterology, Reproductive Medicine and Rheumatology, having authored 39 papers that have together received 2k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (30 papers), Clostridium difficile and Clostridium perfringens research (5 papers), Celiac Disease Research and Management (3 papers), Sperm and Testicular Function (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Electronic Health Records Systems (1 paper) and Liver Diseases and Immunity (1 paper). The work is most often cited by research in Genetics (1.4k citations), Gastroenterology (192 citations), Rheumatology (82 citations), Infectious Diseases (98 citations) and Immunology (55 citations). Timothy E. Ritter has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include Brian G. Feagan, Silvio Danese, Bruce E. Sands, Laurent Peyrin‐Biroulet, William J. Sandborn, Severine A.R.A. Vermeire, Marla C. Dubinsky, Douglas C. Wolf, Stefan Schreiber and Andres J. Yarur. Their work appears in journals such as Gastroenterology, Inflammatory Bowel Diseases, The American Journal of Gastroenterology, ˜The œLancet. Gastroenterology & hepatology and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact